fda withdrew its approval for the cancer medicine ukoniq (umbralisib) due to safety concerns
Published 3 weeks ago • 3 plays • Length 2:01Download video MP4
Download video MP3
Similar videos
-
3:31
fda investigating possible increased risk of death with lymphoma medicine ukoniq (umbralisib)
-
5:01
fda d.i.s.c.o. burst edition: tepmetko (tepotinib) and ukoniq (umbralisib)
-
3:31
fda d.i.s.c.o. burst edition: fda approval of keytruda (pembrolizumab) for patients with metastat...
-
2:39
fda to improve access to experimental cancer drugs
-
3:01
fda d.i.s.c.o. burst edition: fda approval of keytruda (pembrolizumab) in combination with trastu...
-
3:01
fda adds boxed warning for increased risk of death with gout medicine uloric (febuxostat)
-
1:55
august 7, 2024: patients face safety risks with compounded prescription weight-loss drugs
-
3:31
fda d.i.s.c.o. burst edition: fda approval of rezlidhia (olutasidenib) for relapsed or refractor...
-
3:31
fda d.i.s.c.o. burst edition: fda approval of enhertu (fam-trastuzumab deruxtecan-nxki) for unres...
-
5:58
fda d.i.s.c.o.: niraparib in ovarian cancer transcript
-
3:31
fda d.i.s.c.o. burst edition: fda approval of vidaza (azacitidine) for pediatric patients with ne...
-
5:01
fda d.i.s.c.o. burst edition: fda approvals of jemperli (dostarlimab-gxly) for adults with mismat...
-
3:31
fda d.i.s.c.o. burst edition: fda approval of rezurok (belumosudil) for adult and pediatric patie...
-
6:01
fda d.i.s.c.o. burst edition: fda approvals of imbruvica (ibrutinib) for pediatric patients with ...
-
3:01
fda d.i.s.c.o. burst edition: fda approval of ayvakit (avapritinib) for adult patients with advan...
-
5:31
fda d.i.s.c.o. burst edition: fda approval of orencia (abatacept) for prophylaxis of acute graft ...
-
4:50
alliance for hippocratic medicine v. fda
-
2:06
feature -- usda & fda release food safety brochures for those at-risk